Blood Plasma Derivatives Market - Forecast(2025 - 2031)

?????????? ???????????? ?????????????????????? ????????????: ?????????????????? ?????????????????? ?????? ?????????????? ???????? ?????? ????????????????????????

The blood plasma derivatives market size was valued at $ 36,471.8 million in 2020, and is projected to reach $89,767 million by 2030, registering a CAGR of 9.4% from 2021 to 2030.

???????????????? ???????????? @ https://tinyurl.com/ememr2hz

#Plasma is yellow straw colored clear liquid component of blood which is protein salts solution. Three kinds of blood cells (#redbloodcells, #whitebloodcells, and #platelets) are suspended in the plasma. More than 100 proteins (e.g. albumin, fibrinogen, #immunoglobulin, protease inhibitors, & clotting factor) are found in plasma. It starts To maintain the blood pressure & the exchange of mineral such as sodium & potassium.

Blood plasma: The clear liquid part of blood and in which red cells, white cells, and platelets are suspended. It helps in maintaining right #pH balance in the body, and it assists in the transporting nutrients through the body. It consists of over 100 distinct proteins, including albumin, #fibrinogen, immunoglobulins, protease inhibitors, and clotting factors. Plasma derivatives are any products that have been obtained by the fractionation of blood plasma, which are one of the most crucial classes utilized for the treatment of a wide variety of diseases.

?????????????????????????????? (????????, ????????):

#Plasmapheresis Used to treat immune deficiencies, auto-immune diseases, and acute infections.

Examples:

Privigen (CSL Behring)

Hizentra (CSL Behring)

Gammagard (Takeda)

??????????????:

For shock, burns, and #hypoalbuminemia.

Examples:

Albutein (Grifols)

Flexbumin (Baxter)

???????????????? ??????????????:

This is approved for the treatment of #hemophilia and other bleeding disorders.

Examples:

Advate (Takeda)

Hemlibra (Roche)

Kcentra (CSL Behring)

?????????????????????? ??????????????????:

Rabies, tetanus, hepatitis B.

Examples:

HyperHEP B (Grifols)

HyperRAB (Grifols)

HyperTET (Grifols)

???????????????????????? ??????:

Indicated for congenital antithrombin III deficiency.

Examples:

Thrombate III (Grifols)

??????????-1 ??????????????????????:

Used for alpha-1 antitrypsin deficiency.

Examples:

Prolastin-C (Grifols)

Aralast NP (Takeda)

Zemaira (CSL Behring)

??1 ???????????????? ??????????????????:

With hereditary angioedema

Examples:

Berinert (CSL Behring)

Cinryze (Takeda)

Ruconest (Pharming)

?????? ?????? ???????? ???????????? @ https://tinyurl.com/4be2jajk

CVS Health | McKesson | The Cigna Group | Cardinal Health | Johnson & Johnson | HCA Healthcare | Pfizer |AbbVie | Bristol Myers Squibb | Thermo Fisher Scientific | Eli Lilly and Company | Danaher Corporation | Genentech | Amgen | Tenet Healthcare | Stryker | Beckton | GE HealthCare | Viatris

#BloodPlasma #PlasmaDerivatives #HealthcareInnovation #Pharmaceuticals #Biotechnology #MedicalResearch #LifeSciences #Therapeutics

?????????? ??????????????????????:IndustryARC primarily focuses on Cutting Edge Technologies and Newer Applications of the Market. Our Custom Research Services are designed to provide insights on the constant flux in the global demand-supply gap of markets. Our strong analyst team enables us to meet the client research needs at a very quick speed with a variety of options for your business.

We look forward to support the client to be able to better address customer needs; stay ahead in the market; become the top competitor and get real-time recommendations on business strategies and deals.

?????????????? ????: https://tinyurl.com/24vuhuzf

??????????????: https://tinyurl.com/3mb73bb6